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Dear Readers:
It is after 31 years when the Journal of Clinical
Immunology was founded, and 30 years since its first
publication, I retire from the editorship of the Journal of
Clinical Immunology effective January 1, 2011.
It was in late 1979, when I was a young faculty
member at the memorial Sloan–Kettering Center, and
Cornell University Medical College, New York, Profes-
sor Henry Kunkel discussed with me a possibility of
starting a new journal in clinical immunology. He, as
many in the field at that time, was not pleased with the
quality of clinical immunology journals. He later
convinced me that I should start a new journal in
clinical immunology, which I reluctantly accepted. I
approached Plenum Press, with whom I had already
edited a book on Molecular Aspects of Allergic Diseases,
with the idea of starting a new journal. They were
receptive and excited, and the journal was founded in
mid 1980 with its first publication slated for January,
1981. I put together an outstanding group of associate
editors, including Robert Good, Max Cooper, Rebecca
Buckley, Kimishige Ishizaka, and John Kersey, a superb
advisory board, including Frank Austen, Henry Kunkel,
William Paul, Maxime Seligman, Edward Franklin and
Thomas Waldman, and a group of highly dedicated
editorial board members, which later were changed every
4 years. One of my associate editors thought it was not a
good idea to start a new journal and that I might not
succeed; however, he agreed to be on the journal. Henry
did point out some difficulties and obstacles that I might
face from my friends and colleagues to maintain a good
quality journal, and he emphasized that the quality of
papers should never be compromised. I followed his
advice and, in doing so initially, may have made a few
of my friends unhappy; however, during the last 30 years,
the Journal of Clinical Immunology has grown, its impact
factor continues to increase, and it has become one of the
premier journals in clinical immunology.
Recently, I have taken an International project to develop
centers of excellence (COE) in primary immunodeficiency
(PID) in India. It is estimated that there may be more than 1
million children and adults in India with PID who are not
diagnosed and treated. There are few formally trained
physicians/scientists in the area of PID, and the diagnostic
facilities are limited. During the last 6 months, I have been
successful in convincing and securing support from the
Minister of Health and Family Welfare, Director of the
Indian Council for Medical Research, the Secretary of the
Department of Biotechnology in the Ministry of Science
and Technology to establish COE in PID in India. The first
COE will be in operation by early 2011. I always wanted to
give something back to my own country of birth. I am
pleased that I now will have time to dedicate my efforts to
develop premier institutions in PID in India, works for my
charitable foundation (Foundation for Primary Immunode-
ficiency), and help thousands of patients with PID in India.
There will, however, not be any change in my current
position at the University of California at Irvine.
During the last 30 years, I had the pleasure of working
with associate editors, advisory board members, and a large
number of dedicated editorial board members. The success
of the journal is largely because of assistance from associate
editors, advice from the most outstanding advisory board,
and the rigor and fairness with which editorial board
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members have provided critical reviews of the manuscripts
submitted to the journal. I thank you all for the time and
efforts, and the quality of reviews that you provided
through many years. Since I consider the Journal of
Clinical Immunology to be my baby, I leave with some
mixed feelings; however, I am pleased that it will be the
flagship journal of the Clinical Immunology Society, and
the journal will be run by an outstanding editor and a group
of dedicated editorial board members.
Good luck to us, and I wish a successful future for the
Journal of Clinical Immunology.
Sudhir Gupta, M.D., Ph.D.
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